Positron-emission tomography for lung cancer in a tuberculosis-endemic region

Asian Cardiovascular and Thoracic Annals

Volumn 18, Issue 1, 2010, Pages 33-38

  Sit, Alva K Y ^a   Sihoe, Alan D L ^a   Suen, Wai Sing ^a   Cheng, Lik Cheung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Emission computed; Lung neoplasms; Neoplasm staging; Tomography; Tuberculosis; X ray computed

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HONG KONG; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; LUNG TUBERCULOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; SENSITIVITY AND SPECIFICITY; COHORT ANALYSIS; COMORBIDITY; ENDEMIC DISEASE; EVALUATION; LUNG; LUNG TUMOR; MEDIASTINUM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; STATISTICS; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; COMORBIDITY; ENDEMIC DISEASES; FEMALE; HONG KONG; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 77449107564     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492309352119     Document Type: Article

References (20)

1. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:234S-242S.
2. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:243S-265S.
3. Sihoe AD, Yim AP. Lung cancer staging [Review]. J Surg Res 2004;117:92-106.
4. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-866
5. McCain TW, Dunagan DP, Chin R Jr, Oaks T, Harkness BA, Haponik EF. The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies. Chest 2000;118:1610-1615
6. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koëter GH, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;27:254-261
7. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507 (Pubitemid 36706537)
8. Massachusetts Department of Public Health List of Countries with High Rates of Tuberculosis (TB) ± TB Endemic Countries. Available at: http://www.mass.gov/Eeohhs2/docs/dph/cdc/tb/endemic-country-list.pdf. Accessed January 11, 2009.
9. Mountain CF, Dresler CM. Regional lymph classification for lung cancer staging. Chest 1997;111:1718-1723
10. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:52-57
11. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence [Review]. Chest 2003;123:137S-46S.
12. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003;126:1943-1951
13. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004;78:1017-1023
14. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 2004;127:1087-1092
15. Halpern BS, Schiepers C, Weber WA, Crawford TL, Fueger BJ, Phelps ME, et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 2005;128:2289-2297
16. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 2007;109:1068-1077
17. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer. Chest 2007;132:178S-201S.
18. Kernstine KH, Mclaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 2002;73:394-402.
19. Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, et al. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin Nucl Med 2007;32:607-612
20. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. (18)F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging. Published online May 09, 2009:1619-7089.